Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    Zynerba Pharmaceuticals I...

    NASDAQ: ZYNE · Real-Time Price · USD
    1.30
    0.03 (2.36%)
    At close: Oct 10, 2023, 10:00 PM

    Zynerba Pharmaceuticals Cash Flow Statement

    Financials in USD. Fiscal year is January - December.

    undefined peaked at n/a in undefined and hit its lowest at n/a in undefined. Over the past five years, it has declined by undefined%.

    Fiscal Year FY 2022 FY 2021
    Period Ending Dec 31, 2022 Dec 31, 2021
    Net Income
    		 -35.04M -37.31M
    Depreciation & Amortization
    		 219.28K 247.14K
    Stock-Based Compensation
    		 4.33M 5.81M
    Other Working Capital
    		 7.39M -1.48M
    Other Non-Cash Items
    		 n/a n/a
    Deferred Income Tax
    		 n/a n/a
    Change in Working Capital
    		 7.46M -2.21M
    Operating Cash Flow
    		 -23.03M -33.46M
    Capital Expenditures
    		 -154.1K -47.57K
    Cash Acquisitions
    		 n/a n/a
    Purchase of Investments
    		 n/a n/a
    Sales Maturities Of Investments
    		 n/a n/a
    Other Investing Acitivies
    		 n/a n/a
    Investing Cash Flow
    		 -154.1K -47.57K
    Debt Repayment
    		 n/a n/a
    Common Stock Repurchased
    		 n/a n/a
    Dividend Paid
    		 n/a n/a
    Other Financial Acitivies
    		 6.01M 42.16M
    Financial Cash Flow
    		 6.01M 42.16M
    Net Cash Flow
    		 -17.17M 8.65M
    Free Cash Flow
    		 -23.18M -33.51M

    Add to Watchlist